Clinical trial
Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid…
NCT00446784 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00446784 |
|---|---|
| Title | Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis |
| Official title | A Phase 1, Double Blind Study Of The Safety And Pharmacokinetics Of Multiple Doses Of CE 224,535 In Subjects With Rheumatoid Arthritis Receiving Methotrexate |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | CE-224, 535, Methotrexate |
| Enrollment | 20 |
| Start date | Apr 1, 2007 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Mar 13, 2007 |
| Last update posted | May 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: